A 2025 systematic review by Vasireddi and colleagues in HSS Journal screened 544 published papers and identified 36 meeting inclusion criteria 35 preclinical studies and only one human study: an uncontrolled, unblinded, retrospective case series of 12 patients receiving intra-articular BPC-157 for chronic knee pain, in which 7 of 12 (58%) reported self-described relief lasting more than 6 months, with no dose, effect size, or systematically collected adverse events published
Painful hip arthroplasty: definition
The Mechanism of Action The proposed systemic GHK-Cu mechanism is best understood as several interlocking activities that share a common thread: copper handling
Where do users get BPC-157
Its key to stick to the treatment plan and adjust the dose as needed
Future investigations must prioritize product verification, dose characterization, and adverse event surveillance before efficacy can be responsibly evaluated